BI 894416

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for BI 894416, covering 2023-08-14 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Men to Find the Best Formulation of BI 894416 and to Test How This is Taken up in the Body [Phase 1]

See pricing